ConvaTec logo

CTEC - ConvaTec News Story

224p 0.0  0.0%

Last Trade - 4:35pm

Sector
Healthcare
Size
Large Cap
Market Cap £4.51bn
Enterprise Value £5.27bn
Revenue £1.46bn
Position in Universe 199th / 1783

ConvaTec Group PLC - Director Declaration

Mon 28th June, 2021 12:40pm
RNS Number : 3512D
ConvaTec Group PLC
28 June 2021
 

ConvaTec Director Declaration

Reading, United Kingdom (28 June 2021)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Regina Benjamin, Non-Executive Director of the Company, currently serves as a Director of Doximity, Inc. (NYSE: DOCS), which commenced trading on the New York Stock Exchange with effect from 24th June 2021.

 

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations                                         +44 (0)7826 447807

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane/ Hannah Ratcliff            +44 (0)207 466 5000                                                                                                 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

 

.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPPUBPQUPGGGR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.